I think any pharmaceutical manufacturer that has invested in R and D absolutely believes in the power of IP protections to ensure that innovation can continue.
I will speak just on behalf of Pfizer. We moved incredibly quickly during the pandemic to ensure that we were meeting the needs of people here in Canada and globally as quickly as possible. The IP protections that were provided helped us do that, without question. I think without those, we wouldn't have seen the level of co-operation between companies. It would have been impossible for a company like Pfizer to scale up to the level that we did. By working with so many other contractors and manufacturers around the world, we ensured that the global supply of vaccine required to meet the needs during the pandemic were met.